skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells

Journal Article · · Experimental Cell Research
 [1];  [2];  [1];  [2]
  1. Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-0061 (Japan)
  2. Department of Microbiology and Immunology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 (Japan)

Promyelocytic leukemia (PML) nuclear bodies (PML-NBs) are the nuclear structure consisting of various proteins such as PML, SUMO-1, and p53. PML-NBs are implicated in the regulation of tumor suppression, antiviral responses, and apoptosis. In this study, we searched for bioactive metabolites that would promote the formation of PML-NBs in tumor cells. As a result, methyl 2,5-dihydromethylcinnimate (2,5-MeC), a tyrosine kinase inhibitor, enhanced expression and/or stability of PML proteins and induced PML-NB formation in p53 null H1299 cells established from non-small cell lung cancer (NSCLC) and wild-type p53-expressing U2OS cells derived from osteosarcoma. Furthermore, it enhanced apoptosis by exogenously expressed wild type p53 and the expression of p53-responsive genes, such as PUMA and p21, in H1299 cells. 2,5-MeC also activated endogenous p53 and induced apoptosis in U2OS cells. The results suggest that 2,5-MeC is likely to be a promising candidate drug for the clinical treatment of terminal cancer-expressing wild-type p53.

OSTI ID:
20972087
Journal Information:
Experimental Cell Research, Vol. 313, Issue 13; Other Information: DOI: 10.1016/j.yexcr.2007.03.032; PII: S0014-4827(07)00104-8; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
Country of Publication:
United States
Language:
English

Similar Records

Knockdown of hepatoma-derived growth factor-related protein-3 induces apoptosis of H1299 cells via ROS-dependent and p53-independent NF-κB activation
Journal Article · Fri Jul 11 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:20972087

Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53
Journal Article · Fri Apr 15 00:00:00 EDT 2011 · Experimental Cell Research · OSTI ID:20972087

CACUL1/CAC1 attenuates p53 activity through PML post-translational modification
Journal Article · Sun Jan 22 00:00:00 EST 2017 · Biochemical and Biophysical Research Communications · OSTI ID:20972087